John A. McCarthy
Vorstandsvorsitzender bei ZS Genetics, Inc.
Profil
John A.
McCarthy currently works at ZS Genetics, Inc., as Chief Executive Officer & Director from 2014.
Mr. McCarthy also formerly worked at Qteros, Inc., as President & Chief Executive Officer from 2010 to 2011, CryoXtract Instruments LLC, as Chief Executive Officer & Director, Invivo Therapeutics Holdings Corp., as Director from 2015 to 2016, Concentra, Inc., as President-Managed Care Services Division from 1994 to 1998, EXACT Sciences Corp., as Chief Financial Officer & Executive Vice President from 2000 to 2004, Celunol Corp., as Chief Financial Officer & Executive Vice President from 2006 to 2008, Synta Pharmaceuticals Corp., as CFO & SVP-Corporate Development from 2004 to 2005, Microbia, Inc., as Chief Business Officer, Antisoma, Inc., as Chief Financial Officer & Senior Vice President from 2005 to 2006, and Verenium Corp., as Chief Financial Officer & Executive Vice President from 2007 to 2008.
Mr. McCarthy received his undergraduate degree from Lehigh University and Masters Business Admin degree from Harvard Business School.
Aktive Positionen von John A. McCarthy
| Unternehmen | Position | Beginn |
|---|---|---|
ZS Genetics, Inc.
 ZS Genetics, Inc. Medical SpecialtiesHealth Technology ZS Genetics, Inc. develops third-generation deoxyribonucleic acid sequencing platform. It develops a technology platform for directly creating the images of individual deoxyribonucleic acid or ribonucleic acid molecules. The firm offers a single molecule sequencer based on annular dark-field scanning transmission electron microscopy. The company was founded by William R. Glover III and Thomas D. Abert in 2003 and is headquartered in Wakefield, MA. | Vorstandsvorsitzender | 16.12.2014 |
Ehemalige bekannte Positionen von John A. McCarthy
| Unternehmen | Position | Ende |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Vorsitzender | 06.02.2015 |
Qteros, Inc.
 Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Präsident | 18.11.2011 |
| VERENIUM CORP | Finanzdirektor/CFO | 17.11.2008 |
Celunol Corp.
 Celunol Corp. Chemicals: SpecialtyProcess Industries Celunol Corp. produces ethanol and industrial organic chemicals. It develops and commercializes technology that converts low or zero cost agricultural, woody and fibrous materials into ethanol and other specialty chemicals using bio-engineered organisms. The company was founded in 1994 and is headquartered Cambridge, MA. | Finanzdirektor/CFO | 05.05.2008 |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Finanzdirektor/CFO | 01.01.2006 |
Ausbildung von John A. McCarthy
| Lehigh University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Concentra, Inc.
 Concentra, Inc. Medical/Nursing ServicesHealth Services Concentra, Inc. engages in the provision of healthcare solutions. It offers occupational health, physical therapy, health and wellness, physical exams, urgent care, and tests and screening services. The company was founded by Lois E. Silverman and John K. Carlyle in 1979 and is headquartered in Addison, TX. | Health Services |
Celunol Corp.
Celunol Corp. Chemicals: SpecialtyProcess Industries Celunol Corp. produces ethanol and industrial organic chemicals. It develops and commercializes technology that converts low or zero cost agricultural, woody and fibrous materials into ethanol and other specialty chemicals using bio-engineered organisms. The company was founded in 1994 and is headquartered Cambridge, MA. | Process Industries |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
ZS Genetics, Inc.
ZS Genetics, Inc. Medical SpecialtiesHealth Technology ZS Genetics, Inc. develops third-generation deoxyribonucleic acid sequencing platform. It develops a technology platform for directly creating the images of individual deoxyribonucleic acid or ribonucleic acid molecules. The firm offers a single molecule sequencer based on annular dark-field scanning transmission electron microscopy. The company was founded by William R. Glover III and Thomas D. Abert in 2003 and is headquartered in Wakefield, MA. | Health Technology |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
Qteros, Inc.
Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Process Industries |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Verenium Corp. produces cellulosic ethanol derived from multiple biomass feedstocks. It manufactures and markets enzyme products in the fields of animal health and nutrition, grain processing, oilseed processing, oilfield services and other industrial processes such as pulp and paper and textiles. The company was founded in December 1992 and is headquartered in San Diego, CA. | Health Technology |
| CryoXtract Instruments LLC |
